Published in J Control Release on May 18, 2001
Physical approaches to biomaterial design. Nat Mater (2009) 4.01
Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J Control Release (2007) 2.74
Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery. Small (2009) 1.41
Microsphere-based seamless scaffolds containing macroscopic gradients of encapsulated factors for tissue engineering. Tissue Eng Part C Methods (2008) 1.33
Precise control of PLG microsphere size provides enhanced control of drug release rate. J Control Release (2002) 1.27
Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers. Int J Nanomedicine (2008) 1.20
Osteochondral interface tissue engineering using macroscopic gradients of bioactive signals. Ann Biomed Eng (2010) 1.18
NanoCipro encapsulation in monodisperse large porous PLGA microparticles. J Control Release (2007) 1.09
Osteochondral interface regeneration of the rabbit knee with macroscopic gradients of bioactive signals. J Biomed Mater Res A (2011) 1.04
Microsphere-based scaffolds for cartilage tissue engineering: using subcritical CO(2) as a sintering agent. Acta Biomater (2009) 1.01
Osteochondral interface regeneration of rabbit mandibular condyle with bioactive signal gradients. J Oral Maxillofac Surg (2011) 0.97
Osteogenic differentiation of human bone marrow stromal cells in hydroxyapatite-loaded microsphere-based scaffolds. Tissue Eng Part A (2011) 0.97
Three-dimensional macroscopic scaffolds with a gradient in stiffness for functional regeneration of interfacial tissues. J Biomed Mater Res A (2010) 0.96
The potential of encapsulating "raw materials" in 3D osteochondral gradient scaffolds. Biotechnol Bioeng (2013) 0.95
Development of functional biomaterials with micro- and nanoscale technologies for tissue engineering and drug delivery applications. J Tissue Eng Regen Med (2012) 0.94
Encapsulation of protein nanoparticles into uniform-sized microspheres formed in a spinning oil film. AAPS PharmSciTech (2005) 0.92
Effect of different sintering methods on bioactivity and release of proteins from PLGA microspheres. Mater Sci Eng C Mater Biol Appl (2013) 0.90
Monodisperse double-walled microspheres loaded with chitosan-p53 nanoparticles and doxorubicin for combined gene therapy and chemotherapy. J Control Release (2012) 0.88
High-density cell systems incorporating polymer microspheres as microenvironmental regulators in engineered cartilage tissues. Tissue Eng Part B Rev (2012) 0.86
Physicochemical properties and applications of poly(lactic-co-glycolic acid) for use in bone regeneration. Tissue Eng Part B Rev (2013) 0.84
Protein encapsulation in and release from monodisperse double-wall polymer microspheres. J Pharm Sci (2013) 0.84
Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheres. Biomagn Res Technol (2007) 0.83
Tailoring of processing parameters for sintering microsphere-based scaffolds with dense-phase carbon dioxide. J Biomed Mater Res B Appl Biomater (2012) 0.83
Influence of particle size and antacid on release and stability of plasmid DNA from uniform PLGA microspheres. J Control Release (2007) 0.82
Microsphere-Based Scaffolds Carrying Opposing Gradients of Chondroitin Sulfate and Tricalcium Phosphate. Front Bioeng Biotechnol (2015) 0.81
Microfluidic production of single micrometer-sized hydrogel beads utilizing droplet dissolution in a polar solvent. Biomicrofluidics (2013) 0.80
Nanoparticles in porous microparticles prepared by supercritical infusion and pressure quench technology for sustained delivery of bevacizumab. Mol Pharm (2013) 0.80
Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers. Int J Nanomedicine (2015) 0.79
Controlled protein release from monodisperse biodegradable double-wall microspheres of controllable shell thickness. J Control Release (2013) 0.79
Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics. Drug Des Devel Ther (2015) 0.79
Plethora of transitions during breakup of liquid filaments. Proc Natl Acad Sci U S A (2015) 0.78
Preparation of gelatin microbeads with a narrow size distribution using microchannel emulsification. AAPS PharmSciTech (2002) 0.78
Bioactive Microsphere-Based Scaffolds Containing Decellularized Cartilage. Macromol Biosci (2015) 0.78
Pulsatile protein release from monodisperse liquid-core microcapsules of controllable shell thickness. Pharm Res (2014) 0.78
Subcritical CO2 sintering of microspheres of different polymeric materials to fabricate scaffolds for tissue engineering. Mater Sci Eng C Mater Biol Appl (2013) 0.77
The application of microencapsulation techniques in the treatment of endodontic and periodontal diseases. Pharmaceutics (2011) 0.77
Control of drug loading efficiency and drug release behavior in preparation of hydrophilic-drug-containing monodisperse PLGA microspheres. J Mater Sci Mater Med (2010) 0.76
The Effect of Swelling Ratio on the Coulter Underestimation of Hydrogel Microsphere Diameters. Tissue Eng Part C Methods (2015) 0.75
Preparation, Characterization and Evaluation of Drug Release Properties of Simvastatin-loaded PLGA Microspheres. Iran J Pharm Res (2016) 0.75
DNA hydrogel microspheres and their potential applications for protein delivery and live cell monitoring. Biomicrofluidics (2016) 0.75
Microsphere-based scaffolds encapsulating chondroitin sulfate or decellularized cartilage. J Biomater Appl (2016) 0.75
Alginate Microsphere Fabrication Using Bipolar Wave-Based Drop-on-Demand Jetting. J Manuf Process (2011) 0.75
Biosensing by WGM Microspherical Resonators. Sensors (Basel) (2016) 0.75
Microsphere-based scaffolds encapsulating tricalcium phosphate and hydroxyapatite for bone regeneration. J Mater Sci Mater Med (2016) 0.75
Emerging marine diseases--climate links and anthropogenic factors. Science (1999) 10.22
A roadmap for graphene. Nature (2012) 8.66
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med (1999) 5.84
PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol (1998) 5.01
Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair. Science (1995) 4.22
Rapid diagnosis of pulmonary tuberculosis by using Roche AMPLICOR Mycobacterium tuberculosis PCR test. J Clin Microbiol (1995) 4.11
CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol (2001) 3.44
Peroxiredoxin, a novel family of peroxidases. IUBMB Life (2001) 2.91
Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem (1998) 2.66
Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res (2000) 2.64
Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci U S A (2001) 2.62
Papillary cystic and solid tumors of the pancreas: a pancreatic embryonic tumor? Studies of three cases and cumulative review of the world's literature. Surgery (1995) 2.50
Analysis of repeated categorical data using generalized estimating equations. Stat Med (1994) 2.44
Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep (2001) 2.43
Proliferating cell nuclear antigen-dependent abasic site repair in Xenopus laevis oocytes: an alternative pathway of base excision DNA repair. Mol Cell Biol (1994) 2.42
In vitro inhibition of diphtheria toxin action by ammonium salts and amines. J Bacteriol (1965) 2.38
Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis (1998) 2.27
Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects. Psychiatry Res (2000) 2.15
Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J Biol Chem (1993) 2.04
Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem (2000) 2.04
Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol (1991) 2.03
Potential antifolate resistance determinants and genotypic variation in the bifunctional dihydrofolate reductase-thymidylate synthase gene from human and bovine isolates of Cryptosporidium parvum. Mol Biochem Parasitol (1996) 2.02
Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc Natl Acad Sci U S A (1999) 2.02
The development and biology of bradyzoites of Toxoplasma gondii. Front Biosci (2000) 1.84
The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet (2004) 1.79
Mode of inhibition of diphtheria toxin by ammonium chloride. J Bacteriol (1965) 1.79
Nonenzymatic cleavage of proteins by reactive oxygen species generated by dithiothreitol and iron. J Biol Chem (1985) 1.78
The final stages of spliceosome maturation require Spp2p that can interact with the DEAH box protein Prp2p and promote step 1 of splicing. RNA (1995) 1.77
Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. Proc Natl Acad Sci U S A (2001) 1.76
Postoperative chemoradiotherapy for gastric cancer. Ann Oncol (2003) 1.73
Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology (1990) 1.72
Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J Control Release (2003) 1.69
Genetic analysis of the VP1 region of human enterovirus 71 strains isolated in Korea during 2000. Arch Virol (2003) 1.64
Outbreaks of diarrhea associated with Clostridium difficile and its toxin in day-care centers: evidence of person-to-person spread. J Pediatr (1983) 1.63
Proliferating cell nuclear antigen facilitates excision in long-patch base excision repair. J Biol Chem (1999) 1.60
Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results. J Natl Cancer Inst (1993) 1.59
Anxiety disorders during acute bereavement: risk and risk factors. J Clin Psychiatry (1990) 1.57
Magnetic resonance microscopy of the C57BL mouse brain. Neuroimage (2000) 1.56
Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet (1992) 1.55
Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol (1994) 1.51
Congestion of right liver graft in living donor liver transplantation. Transplantation (2001) 1.51
Atomic force microscopy of long and short double-stranded, single-stranded and triple-stranded nucleic acids. Nucleic Acids Res (1996) 1.50
3-D correlation-based speckle tracking. Ultrason Imaging (2005) 1.46
Observations on the developmental patterns and the consequences of pancreatic exocrine adenocarcinoma. Findings of 154 autopsies. Arch Surg (1995) 1.44
FMRFamide-related neuropeptide gene family in Caenorhabditis elegans. Brain Res (1999) 1.44
One micrometer resolution NMR microscopy. J Magn Reson (2001) 1.44
Prospective analysis of outcome after cardiopulmonary resuscitation in critically ill surgical patients. J Am Coll Surg (1995) 1.42
Re: Long-term survival and mortality in prostate cancer treated with noncurative intent. J Urol (1996) 1.41
Short- and long-term clinical effects of primary directional coronary atherectomy for acute myocardial infarction. Cathet Cardiovasc Diagn (1996) 1.40
Removals of hydrogen peroxide and hydroxyl radical by thiol-specific antioxidant protein as a possible role in vivo. Biochem Biophys Res Commun (1993) 1.38
Rapid diagnosis of tuberculosis in various biopsy and body fluid specimens by the AMPLICOR Mycobacterium tuberculosis polymerase chain reaction test. Chest (1998) 1.37
Variation of silica bodies in leaf epidermal long cells within and among seventeen species of Oryza (Poaceae). Am J Bot (1998) 1.37
Measurement of two- and three-nucleon short-range correlation probabilities in nuclei. Phys Rev Lett (2006) 1.37
Unmasking of hydrogen tunneling in the horse liver alcohol dehydrogenase reaction by site-directed mutagenesis. Biochemistry (1993) 1.34
'Designer atoms' for quantum metrology. Nature (2006) 1.33
Induction of an antioxidant protein of Saccharomyces cerevisiae by O2, Fe3+, or 2-mercaptoethanol. Proc Natl Acad Sci U S A (1989) 1.33
The nucleotide sequence and reading frames of a mutant hepatitis B virus subtype adr. Nucleic Acids Res (1989) 1.33
Realization of the quantum Toffoli gate with trapped ions. Phys Rev Lett (2009) 1.33
Cyclophilin a binds to peroxiredoxins and activates its peroxidase activity. J Biol Chem (2001) 1.32
Neuropeptide gene families in the nematode Caenorhabditis elegans. Ann N Y Acad Sci (1999) 1.32
Sleep loss and daytime sleepiness in the general adult population of Japan. Psychiatry Res (2000) 1.30
Facilitating prelinguistic communication skills in young children with developmental delay. J Speech Hear Res (1993) 1.30
Identification of three stage-specific proteinases of Plasmodium falciparum. J Exp Med (1987) 1.30
The influence of lifestyle and health status factors on sleep loss among the Japanese general population. Sleep (2001) 1.30
First observation of the Greisen-Zatsepin-Kuzmin suppression. Phys Rev Lett (2008) 1.29
Reconstitution of proliferating cell nuclear antigen-dependent repair of apurinic/apyrimidinic sites with purified human proteins. J Biol Chem (1999) 1.28
Single molecule detection of direct, homologous, DNA/DNA pairing. Proc Natl Acad Sci U S A (2009) 1.27
Isolation and characterization of a thermophilic lipase from bacillus thermoleovorans ID-1. FEMS Microbiol Lett (1999) 1.26
Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol (1997) 1.26
Copy-number of broad host-range plasmid R1162 is regulated by a small RNA. Nucleic Acids Res (1986) 1.24
Fatty acid interactions with a helix-less variant of intestinal fatty acid-binding protein. Biochemistry (1996) 1.24
The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study. Ann Hematol (1992) 1.24
Restriction enzyme-mediated integration elevates transformation frequency and enables co-transfection of Toxoplasma gondii. Mol Biochem Parasitol (1995) 1.24
PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J Pharm Sci (1999) 1.23
Mouse silver mutation is caused by a single base insertion in the putative cytoplasmic domain of Pmel 17. Nucleic Acids Res (1995) 1.21
Charge-orbital density wave and superconductivity in the strong spin-orbit coupled IrTe2:Pd. Phys Rev Lett (2012) 1.21
Geobacillus toebii sp. nov., a novel thermophilic bacterium isolated from hay compost. Int J Syst Evol Microbiol (2002) 1.20
5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J Virol (2005) 1.19
Effect of frameless stereotaxy on the accuracy of C1-2 transarticular screw placement. J Neurosurg (2001) 1.18
Disruption of the Toxoplasma gondii bradyzoite-specific gene BAG1 decreases in vivo cyst formation. Mol Microbiol (1999) 1.18
Purification and characterization of a second type thioredoxin peroxidase (type II TPx) from Saccharomyces cerevisiae. Biochemistry (1999) 1.17
A conserved subtilisin-like protein TgSUB1 in microneme organelles of Toxoplasma gondii. J Biol Chem (2001) 1.17
Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer. Oncogene (2008) 1.17
Depressive episodes and dysphoria resulting from conjugal bereavement in a prospective community sample. Am J Psychiatry (1990) 1.16
Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus. J Med Virol (2000) 1.15
Use of an in vitro pharmacodynamic model to derive a linezolid regimen that optimizes bacterial kill and prevents emergence of resistance in Bacillus anthracis. Antimicrob Agents Chemother (2008) 1.14
On super-resolution for fetal brain MRI. Med Image Comput Comput Assist Interv (2010) 1.14
Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol (1999) 1.12
Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization. Mol Cell Biol (2001) 1.12
The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res (2000) 1.11
The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53. Oncogene (2011) 1.10
Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patients. Ann Oncol (2010) 1.10
Renal advances in ultrasound elasticity imaging: measuring the compliance of arteries and kidneys in end-stage renal disease. Blood Purif (2005) 1.10
Detection of fecal residue on poultry carcasses by laser-induced fluorescence imaging. J Food Sci (2009) 1.09
Progression of coronary atherosclerosis: is coronary spasm related to progression? J Am Coll Cardiol (1991) 1.09
The C2 domains of Rabphilin3A specifically bind phosphatidylinositol 4,5-bisphosphate containing vesicles in a Ca2+-dependent manner. In vitro characteristics and possible significance. J Biol Chem (1998) 1.09
Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study. Hum Gene Ther (2001) 1.09
Onset of a quantum phase transition with a trapped ion quantum simulator. Nat Commun (2011) 1.09
Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistance. Int J Oncol (2000) 1.09